Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07721766 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training

Study acronym: HyperLa
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The HyperLa study investigates whether a person's "glycolyticness"-the efficiency with which their body uses glycolysis for energy-can predict how much their muscles will grow (hypertrophy) in response to resistance training. Participants will undergo a specialized "vLapeak" test, which measures the maximal rate of lactate accumulation during a 10-second all-out cycling sprint, to determine their individual glycolytic power. Following this initial assessment, participants will complete eight weeks of standardized, twice-weekly resistance training focused on the lower body. The study aims to determine if individuals with higher initial vLapeak values experience greater increases in muscle size compared to those with lower values. This research may help explain why people respond differently to exercise and support the development of personalized training programs.
Trial Details
NCT Number NCT07721766
Lead Sponsor Technical University of Munich
Collaborators: Chemnitz University of Technology, DLR German Aerospace Center, University of Jyvaskyla, University of Limerick, IST University of Applied Sciences Düsseldorf, Institute for Applied Training Science (IAT/FES e.V.)
Conditions
(from sponsor)		 Healthy Volunteers, Muscle Hypertrophy, Glycolysis, Moderately Trainend
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov